Kristen L Dennis1, Nichole R Blatner, Fotini Gounari, Khashayarsha Khazaie. 1. aRobert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine bKnapp Center for Biomedical Discovery, Department of Medicine, University of Chicago, Chicago, Illinois, USA.
Abstract
PURPOSE OF REVIEW: Tumor growth elicits antigen-specific cytotoxic as well as immune suppressive responses. Interleukin-10 (IL-10) is a key immune-suppressive cytokine produced by regulatory T-cells and by helper T-cells. Here, we review pleiotropic functions of IL-10 that impact the immune pathology of cancer. RECENT FINDINGS: The role of IL-10 in cancer has become less certain with the knowledge of its immune stimulatory functions. IL-10 is needed for T-helper cell functions, T-cell immune surveillance, and suppression of cancer-associated inflammation. By promoting tumor-specific immune surveillance and hindering pathogenic inflammation, IL-10 is emerging as a key cytokine in the battle of the host against cancer. SUMMARY: IL-10 functions at the cross-roads of immune stimulation and immune suppression in cancer. Immunological mechanisms of action of IL-10 can be ultimately exploited to develop novel and effective cancer therapies.
PURPOSE OF REVIEW: Tumor growth elicits antigen-specific cytotoxic as well as immune suppressive responses. Interleukin-10 (IL-10) is a key immune-suppressive cytokine produced by regulatory T-cells and by helper T-cells. Here, we review pleiotropic functions of IL-10 that impact the immune pathology of cancer. RECENT FINDINGS: The role of IL-10 in cancer has become less certain with the knowledge of its immune stimulatory functions. IL-10 is needed for T-helper cell functions, T-cell immune surveillance, and suppression of cancer-associated inflammation. By promoting tumor-specific immune surveillance and hindering pathogenic inflammation, IL-10 is emerging as a key cytokine in the battle of the host against cancer. SUMMARY:IL-10 functions at the cross-roads of immune stimulation and immune suppression in cancer. Immunological mechanisms of action of IL-10 can be ultimately exploited to develop novel and effective cancer therapies.
Authors: Susan E Erdman; Jane J Sohn; Varada P Rao; Prashant R Nambiar; Zhongming Ge; James G Fox; David B Schauer Journal: Cancer Res Date: 2005-05-15 Impact factor: 12.701
Authors: Alexander D Edwards; Shivanthi P Manickasingham; Roman Spörri; Sandra S Diebold; Oliver Schulz; Alan Sher; Tsuneyasu Kaisho; Shizuo Akira; Caetano Reis e Sousa Journal: J Immunol Date: 2002-10-01 Impact factor: 5.422
Authors: Elias Gounaris; Ching H Tung; Clifford Restaino; René Maehr; Rainer Kohler; Johanna A Joyce; Hidde L Ploegh; Hidde L Plough; Terrence A Barrett; Ralph Weissleder; Khashayarsha Khazaie Journal: PLoS One Date: 2008-08-13 Impact factor: 3.240
Authors: Janis M Taube; Geoffrey D Young; Tracee L McMiller; Shuming Chen; January T Salas; Theresa S Pritchard; Haiying Xu; Alan K Meeker; Jinshui Fan; Chris Cheadle; Alan E Berger; Drew M Pardoll; Suzanne L Topalian Journal: Clin Cancer Res Date: 2015-05-05 Impact factor: 12.531
Authors: Kristen L Dennis; Abdulrahman Saadalla; Nichole R Blatner; Shuya Wang; Vysak Venkateswaran; Fotini Gounari; Hilde Cheroutre; Casey T Weaver; Axel Roers; Nejat K Egilmez; Khashayarsha Khazaie Journal: Cancer Immunol Res Date: 2015-04-08 Impact factor: 11.151
Authors: Cornelis J M Melief; Thorbald van Hall; Ramon Arens; Ferry Ossendorp; Sjoerd H van der Burg Journal: J Clin Invest Date: 2015-07-27 Impact factor: 14.808
Authors: Yu-Tzu Tai; Chirag Acharya; Gang An; Michele Moschetta; Mike Y Zhong; Xiaoyan Feng; Michele Cea; Antonia Cagnetta; Kenneth Wen; Hans van Eenennaam; Andrea van Elsas; Lugui Qiu; Paul Richardson; Nikhil Munshi; Kenneth C Anderson Journal: Blood Date: 2016-04-28 Impact factor: 22.113
Authors: Luke S Manlove; Jason M Schenkel; Kezia R Manlove; Kristen E Pauken; Richard T Williams; Vaiva Vezys; Michael A Farrar Journal: J Immunol Date: 2016-04-25 Impact factor: 5.422
Authors: Oluwaseyi T Shofolawe-Bakare; Larry D Stokes; Mehjabeen Hossain; Adam E Smith; Thomas A Werfel Journal: Biomater Sci Date: 2020-09-02 Impact factor: 6.843